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INTRODUCTION
  A stroke occurs when the blood supply to the brain is 
disturbed in some way. As a result, brain cells are starved 
of oxygen, glucose and other nutrients. Some of the starved 
cells die and others are damaged, and neurologic deficits 
caused by stroke are mainly due to neuronal death and 
damage. However, there is increasing evidence that 
cerebral endothelial cells play important roles in the 
pathophysiology of stroke. First, ischemia induces the 
expression of leukocyte adhesion receptors such as 
P-selectin, intercellular adhesion molecule-1 (ICAM-1), and 
E-selectin on endothelium which mediates cerebral 
inflammation, thus exacerbating cerebral tissue injury (de 
Vries et al, 1997; del Zoppo & Hallenbeck, 2000). 
Breakdown of blood-brain barrier (BBB) is an another 
pathophysiologically important event which occurs in 
ischemia on endothelium (Betz, 1996). This permeability 
barrier is formed by endothelial cell, inter-endothelial cell 
tight junction, basal lamina, and astrocyte end foot. BBB 
breakdown occurs due to loosening of inter-endothelial tight 
junctions, loss of basal lamina constituents and endothelial 
cell deaths, and leads to cerebral edema and hemorrhagic 
transformation which may be lethal events (Betz, 1996; 
Hamann et al, 1999). Loss of basal lamina is the results 
of activation of plasminogen, secretion of matrix me 
talloprotease and release of granule enzymes from 
leukocytes (Sappino et al, 1993). However, there are few 
studies on the mechanism of cerebral endothelial cell death 
during cerebral ischemia.
  Nuclear factor kappa B (NF-κB) is originally identified 
as a transcription factor which stimulates the transcription 
of immunoglobulin kappa light chain in B lymphocytes (Sen 
& Baltimore, 1986). However, it is a ubiquitous trans-
cription factor and has the important roles in immune 
responses and control of apoptosis (Baeuerle & Baltimore, 
1996), and comprises homo- or hetero-dimer of p65, p50, 
p52, cRel and RelB. NF-κB also acts as cell death factor 
or cell survival factor by transcriptional activation of 
various genes related to cell death and survival such as 
bcl-2 families, p53, and MnSOD (Mattson et al, 2000). In 
non-neuronal systems, NF-κB is usually considered as a 
cell survival factor, but in neuronal system (Karin, 1998), 
especially in ischemic condition, remains the question of 
whether NF-κB is a cell survival factor or a cell death 
factor (Clemens, 2000). Also, little is known about the role 
of NF-κB in cerebral endothelial cell death induced by 
ischemia. In the present study, we sought to elucidate the 
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role of NF-κB in cerebral endothelial cell, bEnd.3 cell, 
death by oxygen-glucose deprivation (OGD), an in vitro 
stroke model.
METHODS
Cell culture
  A mouse cerebral endothelioma cell line, bEnd.3 was 
maintained in Dulbecco's modified eagle medium (DMEM) 
(Invitrogen, Carlsbad, CA, USA) supplemented with 10% 
fetal bovine serum (FBS) (Hyclone, Logan, UT, USA) at 
37oC under a humidified atmosphere of 5% CO2 in air.
OGD
  Confluent bEnd.3 cells were transferred into an 
anaerobic chamber (Forma Scientific, Marietta, OH, USA) 
containing a mixed gas composed of 5% CO2, 10% H2, and 
85% N2 after the culture medium was replaced and washed 
three times with deoxygenated balanced salt solution 
containing no glucose (deoxyBSS0, 116 mM NaCl, 1.8 mM 
CaCl2, 0.8 mM MgSO4, 5.4 mM KCl, 1 mM NaH2PO4 and 
26.2 mM NaHCO3, pH 7.4). Reperfusion was performed by 
returning the cultures to normoxic incubator under 5% 
CO2/95% air and by replacing the culture media with BSS5.5 
(5.5 mM glucose, not deoxygenated).
MTT assay
  MTT (Sigma, St. Louis, MO, USA) in DMEM was added 
at a concentration of 1 mg/ml. After two hours of 
incubation, the cultured cell was lysed with extraction 
solution (25% dimethylformamide, 10% SDS) and incubated 
for 12 hours. Absorbance was at 540 nm read in a 
spectrophotometer (Molecular Devices, Sunnyvale, CA, USA). 
In some experiments, reperfusion was performed for two 
hours in order to recover from energy failure caused by OGD.
Propidium iodine (PI) stain
  Propidium iodine (Sigma, St. Louis, MO, USA) at 1μg/ml 
was added to the culture medium. After 30 min incubation, 
cells were examined under a fluorescence microscope.
Electrophoretic mobility shift assay (EMSA)
  Nuclear extracts were prepared according to the method 
described previously (Lee et al, 1988) with modification (Xu 
et al, 1997). For EMSA, the following oligonucleotide with 
the NF-κB consensus binding sequence was used: (5'- 
AGTTGAGGGGACTTTCCCAGGC-3'). A mutant motif with 
G to C substitution (5'-AGTTGAGGCGACTTTCCCAGGC- 
3') served as a control. Labeling of the oligonucleotide with 
γ-32P-ATP and the EMSA method have previously been 
detailed (Xu et al, 1997). Reactions were started by addition 
of nuclear extracts and allowed for 30 min at room 
temperature. Samples were loaded on 4% polyacrylamide 
non-denaturing gel and electrophoresed for 2 h at 180V. 
The dried gel was exposed to Kodak XR5 film on 
intensifying screen for 10∼20 h at -70oC. For competition 
assay, an unlabeled NF-κB oligonucleotide at 100-fold 
excess was added. For supershift assay, 1μl of anti-p65 or 
anti-p50 antibodies (Santa Cruz Biotechnology, Santa Cruz, 
CA, USA) was incubated with nuclear extract for 30 min 
in room temperature prior to binding reaction.
Western blot
  Cells were rinsed with ice-cold PBS and harvested with 
a cell scraper. Cells were pelleted by centrifugation, and 
the cell pellet was resuspended in lysis buffer [50 mM 
Tris-HCl (pH 8.0), 150 mM NaCl, 1 % Triton X-100, 1μg/ml 
aprotinin, 1μg/ml leupeptin, 0.1 mM phenylmethylsulfonyl 
fluoride]. After centrifugation (15,000 rpm for 15 min at 
4oC), equal amount of proteins from each supernatant were 
resolved by SDS-PAGE and transferred to nitrocellulose 
membranes. Anti-p53 (Neomarker, Fremont, CA, USA), 
anti-bcl-2 and anti-bax (Santa Cruz Biotechnology, Santa 
Cruz, CA, USA) antibodies were used as primary anti-
bodies, and corresponding horseradish peroxidase-con-
jugated mouse IgG and rabbit IgG were used as secondary 
antibodies. ECL reagent (Amersham, Bucking hamshire, 
UK) was used for antigen detection in all experiments.
Immunocytochemistry
  Cells were fixed with 4% paraformaldehyde in 100 mM 
phosphate buffer, washed twice and permeabilized with 
0.2% Triton X-100. Non-specific binding was blocked by 1% 
bovine serum albumin. Anti-p65 and biotinylated anti- 
rabbit antibodies were used as primary and secondary 
antibodies, respectively. Biotinylated peroxidase-avidin 
complex was added, and cells were finally stained with 0.5 
mg/ml diaminobenzidine for 5 min.
RESULTS
OGD induced bEnd.3 cell death, but no reperfusion 
injury
  Fig. 1 shows the phase contrast morphology (Fig. 1A, C) 
and propidium iodine staining of bEnd.3 cells exposed to 
BSS5.5 (control group) and OGD for 14 h. Control culture 
showed normal cell bodies, bright cell margin, and no cells 
stained by PI (Fig. 1B). However, 14-h OGD led to almost 
100% cell death, confirmed by PI staining (Fig. 1D). The 
extents of OGD-induced cell death after 8 h, 10 h, 12 h 
and 14 h of OGD were 10%, 35%, 60% and 85%, respectively 
(Fig. 2A).
  In many experiments using in vitro or in vivo ischemia, 
reperfusion exacerbated ischemic neuronal injury (Bulkley, 
1987). This reperfusion injury can occur in clinical situ-
ations of stroke and limit the indications of revasculari-
zation therapy. Therefore, it was of importance to examine 
whether reperfusion exacerbated OGD-induced cell death 
in vascular endothelial cells. As shown in Fig. 2B, 
reperfusion following OGD did not further increase the 
extent of OGD induced death of bEnd.3 cells. Therefore, 
in the following experiments, we used OGD model without 
reperfusion instead of OGD/reperfusion paradigm.
OGD activated NF-kB
  The DNA binding activity of NF-κB, assayed by EMSA, 
gradually increased up to 6 h of OGD (Fig. 3A), and the 
specificity of DNA binding was confirmed by competition 
assay (Fig. 3B). Unlabeled oligonucleotides of wild type and 
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mutant NF-κB, AP-1 and SP-1 in 100-fold excess were used 
in binding reaction. The NF-κB-DNA complex signal 
disappeared only by wild type oligonucleotide, indicating 
that the two bands were NF-κB specific. Supershift assay 
showed that the two bands contained p50 and p65 subunits 
of NF-κB (Fig. 3C). Immunocytochemistry was carried out 
with anti-p65 antibody to confirm nuclear translocation of 
NF-κB by OGD. As seen in Fig. 3D and E, nuclear 
translocation of p65 by OGD was observed, providing an 
another evidence of NF-κB activation by OGD.
IkBa was neither phosphorylated on 32Ser, nor 
degraded
  To elucidate the mechanism of OGD-induced NF-κB 
activation, we assayed the phosphorylation on 32Ser and 
subsequent degradation of IκBα, which are considered as 
the mechanism of TNFα-induced NF-κB activation. As 
shown in Fig. 4A, IκBα was phosphorylated on 32Ser and 
degraded upon TNFα treatment, as expected. In the case 
of OGD-induced NF-κB activation, however, IκBα was 
neither phosphorylated on 32Ser nor degraded (Fig. 4B). 
It was reported that 42Tyr of IκBα could be pho-
sphorylated by hypoxia and in this circumstances. NF-κB 
was activated without degradation of IκBα (Imbert et al, 
1996; Koong et al, 1994). Therefore, we assayed whether OGD 
could phosphorylate IκBα on 42Tyr in endothelial cells. Cell 
lysates were immunoprecipitated with anti-IκBα antibody 
and were immunoblotted with anti-phospho tyrosine anti-
body. In this experiment, OGD did not phosphorylate IκBα 
on 42Tyr, while pervanadate, a tyrosine phosphatase 
inhibitor, did (Fig. 4C).
Fig. 1. OGD-induced bEnd.3 cell death. (A, C) Phase contrast image of control and 14-h OGD group.
(B, D) Propidium iodine staining of control and 14-h OGD group.
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Fig. 2. Extent of OGD-induced bEnd.3 cell death. (A) bEnd.3 cells
were treated with OGD for 8 h, 10 h, 12 h and 14 h. Subsequently,
the extent of cell death was assayed by MTT method. (B) 
Reperfusion following 0 h-, 10 h- and 12 h-OGD was performed up
to 24 h. The extent of cell death was assayed by MTT method.
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Fig. 4. IκBα phosphorylation on 32Ser or 42Tyr and degradation by OGD. (A, B) Western blots with anti-IκBα and anti-32 Ser-phospho-IκBα
antibodies. The treatments of TNFα and OGD were performed as indicated above. (C) Cells were treated as indicated above, harvested
and lysed. Pervanadate (pV) treatment was performed by addition of 100μM sodium vanadate and 0.5μM hydrogen peroxide. The whole
cell lysates were immuno precipitated with anti-IκBα antibody and immunoblotted with anti-IκBα antibody and anti-phosphotyrosine 
antibody. Arrow head shows IκBα having phosphotyrosine.
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Fig. 3. OGD-induced NF-κB activation. (A) Time course of OGD- induced NF-κB activation. bEnd.3 cells were
treated with OGD. At the time indicated, cells were washed twice with cold PBS and harvested. EMSA was 
performed as described in the text. (B) Competition assay. Various unlabeled oligonucleotides indicated above
at 100-fold excess were added in the probe-DNA binding reactions. (C) Supershift assay. Supershift experiments
were performed by adding anti-p65, anti-p50, anti-p52, anti-cRel and anti-RelB antibodies to the binding 
reactions. (D, E) Immunocytochemistry of OGD-induced nuclear translocation of p65. bEnd.3 cells were cultured
on glass cover slip. After 4 h treatment with OGD, the cells were fixed and immunostained by anti-p65 antibody
followed by biotinylated anti-rabbit antibody. The stained cultures were observed under light microscope.
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Effects of three NF-kB inhibitors on OGD-induced 
NF-kB activation and bEnd.3 cell death
  PDTC is a well-known inhibitor of NF-κB, and we 
recently reported that PDTC inhibition of NF-κB activation 
required zinc (Kim et al, 1999). Therefore, we used PDTC 
plus zinc as a NF-κB inhibitor, and Fig. 5A and D show 
that PDTC plus zinc inhibited NF-κB activation caused by 
OGD and exacerbated OGD-induced bEnd.3 death. The 
mechanism of aspirin, an another NF-κB inhibitor, is 
thought to be competitive inhibition against ATP binding 
to IκB kinase (IKK) (Kopp and Ghosh, 1994). As seen in 
Fig. 5B and E, aspirin treatment inhibited NF-κB activa-
tion caused by OGD and increased OGD-induced bEnd.3 
cell death. Caffeic acid phenethyl ester (CAPE) is antio-
xidant and has also been shown to be a potent inhibitor 
of NF-κB (Natarajan et al, 1996). The treatment of 
endothelial cells with CAPE also showed inhibition of NF-
κB activation and augmentation of cell death (Fig. 5C, F). 
These results imply that OGD-induced NF-κB activation 
of bEnd.3 cells would be a cell survival factor and that 
elimination of this factor led to exacerbation of cell death.
OGD did not change the amounts of bcl-2, bax and 
p53
  To elucidate the mechanism of NF-κB to act as a cell 
survival factor, we observed the changes in protein levels 
of bcl-2, bax and p53, which are well-known cell 
survival/death factors and whose expressions are regulated 
by NF-κB activity. However, OGD and OGD with PDTC 
plus zinc did not change the level of any of the three factors 
(Fig. 6).
DISCUSSION
  Cerebral endothelial cell dysfunction plays important 
Fig. 5. Effects of PDTC plus zinc on OGD-induced NF-κB activation and cell death. (A, B, C) EMSA of NF-κB. OGD
was carried out with or without following drugs: 50μM PDTC plus 0.5 to 1μM zinc sulfate (P50/Z0.5, P50/Z1), 1 to 
10 mM aspirin (Asp1, 10) and 0.2 to 20μM CAPE (CAPE 0.2, 2, 20). After treatments, nuclear proteins were extracted
and EMSA was performed. (D, E, F) MTT assay. After the treatments as indicated above, the extent of cell death was
assayed by MTT method.
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Fig. 6. Effects of PDTC plus zinc on the amounts of bcl-2, bax and
p53. OGD was performed for 4 h with or without 50μM PDTC plus
1μM zinc sulfate (P50/Z1). After treatments, cells were washed 
with cold PBS and lysed. The whole cell lysates were analyzed for
bcl-2, bax and p53 abundance by Western blot.
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roles in the pathophysiology of stroke. In the present study, 
we focused on cerebral endothelial cell death and the role 
of NF-κB activation using in vitro model, OGD. The results 
showed that NF-κB was activated in response to OGD. NF-
κB activation by various stimuli, including TNFα, usually 
occurred within 1 h and was terminated within 2 hrs after 
stimulation (Schmitz & Baeuerle, 1995). However, NF-κB 
activation induced by OGD in the present experiment 
increased gradually up to 6 h. This phenomenon suggested 
that OGD might have a mechanism of NF-κB activation 
different from those of typical stimulators. Therefore, the 
mechanism of OGD-induced NF-κB activation was in-
vestigated in more detail. As shown above, NF-κB was 
activated by OGD without degradation of IκBα, following 
phosphorylation on 32Ser which was considered to be a 
typical mechanism of NF-κB activation by TNFα. Earlier 
studies showed that hypoxia activated NF-κB through 
dissociation of IκBα from NF-κB without degradation 
which was due to phosphorylation of IκBα on 42Tyr 
(Koong et al, 1994; Imbert et al, 1996). We assayed IκBα 
phosphorylation on 42Tyr, however, could not observe the 
42Tyr phosphorylation by OGD. Since several studies 
suggested that IκBβ was involved in long-lasting 
activation NF-κB (Johnson et al, 1996; Phillips & Ghosh, 
1997), the possibility of IκBβ involvement in NF-κB 
activation by OGD remains to be studied.
  When NF-κB activation was inhibited by three 
inhibitors, PDTC plus zinc, aspirin and CAPE, OGD- 
induced cell death of bEnd.3 increased, suggesting that 
OGD-induced NF-κB activation could be a cell survival 
factor. Many genes responsive to NF-κB activation play 
roles of cell survival or death factors. Cell survival factors 
include bcl-2, bcl-xL, MnSOD and IAPs, and cell death 
factors include p53, bax, iNOS and leukocyte adhesion 
molecules (Clemens, 2000). It was reported that hy 
poxia-induced endothelial apoptosis occurred through NF-
κB-mediated bcl-2 suppression which implied NF-κB as 
a cell death factor (Matsushita et al, 2000). In the present 
study, however, aortic endothelial cells were used instead 
of cerebral microvascular endothelial cells which have 
unique features. In contrast, there are several reports that 
bcl-2 was upregulated by NF-κB activation (Heckman et 
al, 2002; Poulaki et al, 2002). However, in the present 
study, we could not observe changes in the amounts of bcl-2, 
bax and p53 by OGD. Other possible molecules remain to 
be investigated.
  Inducible nitric oxide synthase (iNOS) has been shown 
to be upregulated by OGD and resulting increase of nitric 
oxide induces cerebral endothelial cell death (Xu et al, 
2000). iNOS is upregulated by NF-κB activation (Bereta 
et al, 1995). These considerations suggest that NF-κB 
might be a cell death factor. Nitric oxide cytotoxicity is due 
to peroxynitrite formed from superoxide (Pryor & Squa-
drito, 1995; Squadrito and Pryor, 1995), however, several 
studies showed that iNOS could play a role of cell survival 
factor (Kim, 1997; Suschek et al, 1999). Therefore, the 
question of whether iNOS could act as a cell survival factor 
in OGD-induced bEnd.3 cell death is an another topic to 
be studied.
  Aspirin may be used to prevent recurrence of stroke 
(Carolei et al, 1986; Grotta et al, 1985; Joseph et al, 1992). 
Clinically, aspirin is expected to act as an antiplatelet agent 
via inhibition of cyclooxygenase (Pedersen and FitzGerald, 
1984). However, it is also important to consider that aspirin 
may act as a NF-κB inhibitor. Based on our data together 
with findings by others, this property of aspirin may cause 
a disastrous event; hemorrhagic transformation through 
exacerbation of cerebral endothelial cell death caused by 
ischemia. Hemorrhagic transformation may outweigh 
suggested neuroprotective effects of aspirin (Grilli et al, 
1996). Therefore, it is very important to consider that 
administration of aspirin in order to prevent stroke 
recurrence may be harmful in certain conditions.
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